Discovery of a small-molecule protein kinase Cδ-selective activator with promising application in colon cancer therapy
Protein kinase C (PKC) isozymes play major roles in human diseases, including cancer. Yet, the poor understanding of isozymes-specific functions and the limited availability of selective pharmacological modulators of PKC isozymes have limited the clinical translation of PKC-targeting agents. Here,… Read more ›